CureVac Current Deferred Revenue from 2010 to 2026
| CVAC Stock | USD 4.66 0.00 0.00% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 51.3 M | Current Value 56.5 M | Quarterly Volatility 39.1 M |
Check CureVac NV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CureVac NV's main balance sheet or income statement drivers, such as Tax Provision of 34.6 M, Net Interest Income of 14.9 M or Interest Income of 14.9 M, as well as many indicators such as Price To Sales Ratio of 1.51, Dividend Yield of 0.0 or PTB Ratio of 1.16. CureVac financial statements analysis is a perfect complement when working with CureVac NV Valuation or Volatility modules.
CureVac | Current Deferred Revenue | Build AI portfolio with CureVac Stock |
Analyzing CureVac NV's Current Deferred Revenue over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Current Deferred Revenue has evolved provides context for assessing CureVac NV's current valuation and future prospects.
Latest CureVac NV's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of CureVac NV over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. CureVac NV's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CureVac NV's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
CureVac Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 29,820,434 | |
| Geometric Mean | 15,013,435 | |
| Coefficient Of Variation | 131.11 | |
| Mean Deviation | 28,085,923 | |
| Median | 5,777,000 | |
| Standard Deviation | 39,097,542 | |
| Sample Variance | 1528.6T | |
| Range | 152.2M | |
| R-Value | 0.55 | |
| Mean Square Error | 1140.7T | |
| R-Squared | 0.30 | |
| Significance | 0.02 | |
| Slope | 4,243,503 | |
| Total Sum of Squares | 24457.9T |
CureVac Current Deferred Revenue History
About CureVac NV Financial Statements
CureVac NV stakeholders use historical fundamental indicators, such as CureVac NV's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although CureVac NV investors may analyze each financial statement separately, they are all interrelated. For example, changes in CureVac NV's assets and liabilities are reflected in the revenues and expenses on CureVac NV's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CureVac NV. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 51.3 M | 56.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CureVac NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CureVac NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Curevac Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Curevac Nv Stock:Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Will Biotechnology sector continue expanding? Could CureVac diversify its offerings? Factors like these will boost the valuation of CureVac NV. Projected growth potential of CureVac fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CureVac NV data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.24 | Earnings Share 0.67 | Revenue Per Share | Quarterly Revenue Growth (0.89) | Return On Assets |
The market value of CureVac NV is measured differently than its book value, which is the value of CureVac that is recorded on the company's balance sheet. Investors also form their own opinion of CureVac NV's value that differs from its market value or its book value, called intrinsic value, which is CureVac NV's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because CureVac NV's market value can be influenced by many factors that don't directly affect CureVac NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between CureVac NV's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CureVac NV should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, CureVac NV's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.